Operated by OMRON HEALTHCARE MANUFACTURING INDIA Pvt. Ltd., the approximately 24,000-square-metre factory is located at ORIGINS by Mahindra and has five production lines serving the Indian market.
In 2025, an estimated 11.5 million people living with HIV worldwide were aged 50 and above, representing approximately 29% of the global population living with the virus.
The consignment includes 6,000 personal protective equipment (PPE) kits, 60 powered air-purifying respirators, 30,000 N95 masks, and more than 86,000 sample transport kits.
The acquisition will enable Cotecna to serve pharmaceutical companies with a broader range of regulatory compliant testing services, while improving its capacity to respond to customer requirements across key markets.
The Paonta Sahib site covers 14 acres and includes approximately 39,000 square metres of built-up manufacturing space.
Her contributions to patient access, community engagement and healthcare capacity have earned her recognition including the British Empire Medal.
Novartis India’s board approved the transaction before the company signed an asset purchase agreement and trademark assignment deeds with Pfizer and Pfizer Products.
Ahead of the Union World Conference on Lung Health 2026, the End TB Dialogues session featured Dr MP Nezeeda, State TB Officer of Lakshadweep, who shared insights into the territory’s progress towards TB elimination.
The company said India’s Central Drugs Standard Control Organisation (CDSCO) approved the intravenous (IV) formulation, while Taiwan’s Food and Drug Administration (TFDA) approved both Hunterase IV and Hunterase ICV.
Rather than creating entirely new programmes, HPPI has worked to strengthen TB services within established HIV platforms while using a person-centred, community-led approach.